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Cardiac myocytes (CMs) proliferate robustly during fetal life but withdraw permanently
from the cell cycle soon after birth and undergo terminal differentiation.This cell cycle exit is
associated with the upregulation of a host of adult cardiac-speciﬁc genes.The vast majority
of adult CMs (ACMs) do not reenter cell cycle even if subjected to mitogenic stimuli. The
basis for this irreversible cell cycle exit is related to the stable silencing of cell cycle genes
speciﬁcally involved in the progression of G2/M transition and cytokinesis. Studies have
begun to clarify the molecular basis for this stable gene repression and have identiﬁed
epigenetic and chromatin structural changes in this process. In this review, we summarize
the current understanding of epigenetic regulation of CM cell cycle and cardiac-speciﬁc
gene expression with a focus on histone modiﬁcations and the role of retinoblastoma
family members.
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INTRODUCTION
The fetal heart increases in size throughout development via pro-
liferation of CMs but switches to mainly hypertrophic growth of
CMswith limited proliferation soon after birth, undergoing termi-
nal differentiation which is associated with permanent cell cycle
exit (Ahuja et al., 2007; Mollova et al., 2013; Naqvi et al., 2014).
Terminal differentiation in ACMs is characterized by two distinct
phenomena: the upregulation of a panel of cardiac-speciﬁc adult
genes and the permanent withdrawal from cell cycle (Ahuja et al.,
2007). The inability of ACMs to proliferate has been linked to
the fact that E2F-dependent cell cycle genes speciﬁcally involved
in regulating G2/M and cytokinesis are not re-expressed after
growth stimuli in ACMs. Recent studies suggest the upregula-
tion of adult cardiac-speciﬁc genes together with the silencing of
cell cycle genes may be mediated by epigenetic mechanisms (Sdek
et al., 2011).
Epigenetic mechanisms regulate chromatin structure (Li and
Reinberg, 2011), whichmodulates gene expression and plays a cru-
cial role in diverse biological events such as the speciﬁcation and
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differentiation of various cell types (Chen and Dent, 2014). Epige-
netic marks have traditionally been thought to be stable, however
the recent identiﬁcation of histone modiﬁcation enzymes suggests
that epigenetic regulation can be a dynamic and reversible pro-
cess (Kooistra and Helin, 2012). This review focuses on epigenetic
regulation inCMs and its role in cell cycle control and terminal dif-
ferentiation with a focus on histone modiﬁcations and Rb family
members.
EPIGENETIC REGULATION OF GENE EXPRESSION AND
SILENCING
Epigenetics is typically deﬁned as the regulatory mechanisms of
gene activity that are not due to changes in DNA sequence. These
include modiﬁcations of DNA and histone proteins, which affect
chromatin structure, and microRNA. In the nuclei of eukaryotic
cells, DNA is wrapped around an octamer of histone proteins
that are packed into higher-order chromatin structures. Epi-
genetic regulation involves covalent modiﬁcation of either of
DNA (DNA methylation) or of nucleosomes, which is primarily
through post-translational modiﬁcation of histones (acetylation,
methylation, phosphorylation, ubiquitination, sumoylation, ribo-
sylation, deamination, and proline isomerization; Chen and
Dent, 2014). These epigenetic post-translational modiﬁcations
are tightly controlled by speciﬁc enzymes, for example HATs
and HDACs as well as HMTs and HDMs. There are two fun-
damental types of chromatin: euchromatin and heterochromatin.
Euchromatin is typically associated with transcriptionally active
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genes because its looser structure is accessible to TFs. In contrast,
heterochromatin has a high-density structure that prevents tran-
scriptional machinery access and gene expression (Johnson et al.,
2013).
Euchromatin formation is typically associated with histone
acetylation, on the other hand, heterochromatin formation is
associated with speciﬁc histone methylations. The effect of his-
tone methylation is dependent on which amino acid residue of
the histone is methylated, and whether the residue is mono, di,
or trimethylated (me1, me2, and me3, respectively; Chen and
Dent, 2014). For example, methylation of the lysine 4, 36, or 79
lysine residue of histone 3 (H3K4me,H3K36me, andH3K79me) at
gene promoters is associated with transcription activation, while
methylation of the 9th or 27th lysines (H3K9me, H3K27me) is
linked to heterochromatin formation and gene repression (Chen
and Dent, 2014). H3K9me3 is a potent inducer of stable hete-
rochromatin by recruiting HP1s (Canzio et al., 2013). H3K27me3
is thought to be more dynamically regulated and mark repressed
but poised genes (Rada-Iglesias et al., 2011; Lee et al., 2012). The
addition of methyl groups on the lysine and arginine residues
of histones is catalyzed by HMTs, while the removal of methyl
groups is mediated by HDMs. For all the known lysine residues of
HMT activity, counteracting HDMs have been identiﬁed, with the
exception that the H3K79 HDM is not known, although evidence
suggests methylations of this mark are reversible (Kooistra and
Helin, 2012).
EPIGENETIC REGULATION OF CARDIAC-SPECIFIC GENE
EXPRESSION
During cardiac differentiation, the epigenetic landscape changes
dramatically, which is required for appropriate cardiac differenti-
ation (Paige et al., 2012; Wamstad et al., 2012). The establishment
and maintenance of a speciﬁc gene expression program includes
activation of cardiac-speciﬁc genes and cell cycle inhibitors as well
as stable repression of non-cardiac genes and cell cycle progression
genes.
HATs, HDACs, AND HISTONE ACETYLATION
The HAT most studied in cardiac development is p300. p300 is
highly expressed in embryonic myocardium but the level declines
after birth (Schueler et al., 2012). 3,000–5,000 potential enhancers
are associated with p300 in fetal and adult hearts (Blow et al.,
2010; May et al., 2012), suggesting an important role in CM devel-
opment. p300-deﬁcient mice are embryonic lethal at E9-11.5 with
heart malformations and reduced expression of cardiac-speciﬁc
genes such as αMHC and αSA (Yao et al., 1998; Partanen et al.,
1999). Knock-in experiments using an acetyltransferase activity-
deﬁcient p300 mutant demonstrated that p300 acetyltransferase
activity is speciﬁcally required for cardiac development (Shikama
et al., 2003). p300 interactswithGATA4,Nkx2.5, andMef2c,which
are key TFs regulating CM gene expression and differentiation,
at promoters of their target genes (Sun et al., 2010; Figure 1A).
In addition, expression of cardiac-speciﬁc genes such as atrial
natriuretic peptide (ANP) and brain natriuretic peptide (BNP)
correlates with p300 occupancy and histone acetylation on their
promoters (Hasegawa et al., 1997; Slepak et al., 2001; Mathiyala-
gan et al., 2010; Schlesinger et al., 2011; Schueler et al., 2012).
FIGURE 1 | Model of epigenetic gene regulation in cardiac myocytes.
Cardiac differentiation is associated with activation of cardiac-speciﬁc
genes and silencing of non-cardiac and cell cycle genes.
(A) Cardiac-speciﬁc gene regulation: cardiac-speciﬁc transcription factors
(CTFs) recruit histone acetyltransferases, such as p300, transferring acetyl
groups to histone H3 and/or H4. Also they recruit histone demethylases
such Kdm4a and UTX to remove silencing methyl marks from H3K9me3
and H3K27me3, resulting in activation of cardiac-speciﬁc genes.
(B) Non-cardiac gene repression: HDACs remove acetyl groups from H3
and/or H4 and histone methyltransferases such as Suv39h1 and PRC2 put
methyl groups on H3K9 and H3K27, respectively, promoting tighter histone
packing and silencing non-cardiac genes. (C) Cell cycle gene silencing:
Rb/E2F complex targets HP1γ on positive cell cycle gene promoters. HP1γ
spreads H3K9me3 likely through recruitment of Suv39h1 and
self-assembles to condensate chromatin, resulting in the packaging and
silencing of positive cell cycle genes in heterochromatin. H3K27me3 is also
enriched by an unknown mechanism but probably mediated by PRC2.
Consistent with this, inhibition of p300 resulted in decreased
expression of cardiac-speciﬁc genes such as α-MHC and β-MHC
and interestingly the expression of cardiac TFs such as Mef2c,
Nkx2.5, and Hands were also decreased (Hasegawa et al., 1997;
Lin et al., 1997; McFadden et al., 2000; Poizat et al., 2000; Dai et al.,
2002). Cardiac TFs such asGATA4 andMef2c can be directly acety-
lated by p300 and the acetylation potentiates DNA binding and
transcriptional activity (Kawamura et al., 2005; Ma et al., 2005).
CBP, a HAT structurally related to p300, is expressed in embryonic
hearts, but CBP-deﬁcient embryos don’t show abnormal heart
formation (Tanaka et al., 2000; Chen et al., 2009). Males absent on
the ﬁrst (MOF) protein, a HAT belonging to the MYST (MOZ,
Ybf2/Sas3, Sas2, and TIP60) family member, is down-regulated in
human failing hearts and mouse hypertrophic hearts (Qiao et al.,
Frontiers in Genetics | Epigenomics and Epigenetics November 2014 | Volume 5 | Article 375 | 2
Oyama et al. Epigenetic regulation of cardiac proliferation
2014). Cardiac-speciﬁc MOF overexpression ameliorated TAC-
induced cardiac hypertrophy, however it was not determined if
this protection was related to HAT activity or targeting of spe-
ciﬁc genes (Qiao et al., 2014). Other HATs such as Gcn5 have
been implicated in cardiac differentiation in vitro but their relative
importance is unknown (Li et al., 2010).
The effects of HATs are counteracted by HDACs, which typ-
ically repress gene activation. HDACi TSA promotes acetylation
of H3 and H4 and CM differentiation in vitro (Kawamura et al.,
2005; Karamboulas et al., 2006). Cardiac-speciﬁc deletion of
either HDAC1 or HDAC2 singly does not evoke a phenotype;
however, deletion of both genes results in neonatal lethality,
accompanied by cardiac arrhythmias and dilated cardiomyopathy
(Montgomery et al., 2007). Mice with cardiac-speciﬁc overexpres-
sion of HDAC3 show a decrease in global H4 acetylation and
an increased thickness of myocardium which is due to cardiac
hyperplasia without hypertrophy (Trivedi et al., 2008). The hyper-
plasia is related to suppression of Cdk inhibitors such as p21cip1,
p27kip1, p57kip2, p18inc4c, and p15inc4b. In contrast, mice with a
cardiac-speciﬁc deletion of HDAC3 survived up to 4months of age
but demonstrated massive cardiac hypertrophy, myocardial lipid
accumulation and elevated triglyceride levels (Montgomery et al.,
2008). Indeed, ChIP assays show that HDAC3 co-occupies pro-
moters of numerous genes involved in metabolic regulation with
PPARα. It seems that HDAC3 is an important regulator of CM
proliferation and energymetabolism during cardiac development.
Interestingly global histone acetylation is unchanged in HDAC3
KOmice, suggesting that the effects of HDAC3 deﬁciency are very
speciﬁc. HDAC4, a class II HDAC, has an anti-hypertrophic role
through Mef2 suppression. Recent studies suggested that HDAC4
suppresses Mef2 in a histone deacetylation activity independent
manner (Backs et al., 2011; Hohl et al., 2013). Indeed histone
acetylation did not change on hypertrophic gene promoters when
HDAC4 nuclear activity was reduced (Hohl et al., 2013). HDAC5
andHDAC9arehighly enriched in theheart and their functions are
overlapping during cardiac development (Haberland et al., 2009).
Single HDAC5 or HDAC9 KO mice are viable without apparent
cardiac defects but mice lacking both HDAC5 and HDAC9 are
embryonic or early postnatal lethal with ventricular septal defects,
thin-walled myocardium and abnormality of CMs (Zhang et al.,
2002; Chang et al., 2004). Since HDAC5 and HDAC9 interact with
Mef2 to suppress its transcriptional activity (Zhang et al., 2002;
Chang et al., 2004), the developmental cardiac defects in the dou-
ble mutant mice are likely resulted from aberrant activation of
Mef2. Interestingly it has been shown recently that HDAC can
also be acetylated during cardiac hypertrophy, which alters their
function (Eom et al., 2014). Numerous reports using inhibitors
and gene manipulation techniques have revealed the importance
of HAT/HDAC in cardiac development. However, the speciﬁc tar-
get genes and the histone acetylation-independent mechanism of
each HAT/HDAC and their roles in cardiac development require
further study.
HMTs, HDMs, AND HISTONE METHYLATION
There is also increasing evidence demonstrating the impor-
tance of histone methylation in regulating cardiac phenotypes
(Gottlieb et al., 2002; Barski et al., 2007; Nimura et al., 2009; Fujii
et al., 2011;Movassagh et al., 2011; Tao et al., 2011; He et al., 2012a;
Lee et al., 2012). Recent exome sequencing analysis revealed that
congenital heart disease cases show a marked excess of de novo
mutations in genes involved in H3K4 and H3K27 modiﬁcations
(Zaidi et al., 2013). ACMs with inducible, cardiac-speciﬁc KO
of H3K4 HMT subunit, PAX interacting (with transcription-
activation domain) protein 1 (PTIP), showed altered expression
of genes involved in conduction, such as Kcnip2, but not genes
involved in hypertrophy, such as β-MHC and ANP (Stein et al.,
2011). Speciﬁc deletion of PTIP in ACMs led to dysregulated
sodium and calcium handling, abnormal EKGs, and susceptibility
to ventricular premature beats, but no abnormalities of cardiac
growth. Smyd1 is a cardiac and skeletal muscle restricted chro-
matin remodeling protein that can also methylate H3K4 in vitro,
suggesting it may function as a muscle-speciﬁc transcription acti-
vator (Sims et al., 2002; Tan et al., 2006; Sirinupong et al., 2010).
Smyd1 deﬁcient mice die in utero secondary to abnormal CMs
maturation and right ventricular development (Gottlieb et al.,
2002). Consistent with the right ventricular development defect,
the expressions of Hand2 and Irx4 are downregulated in hearts
lacking Smyd1 (Gottlieb et al., 2002; Park et al., 2010). Muscle-
speciﬁc TF skNAC is a major partner for Smyd1 in the developing
heart (Park et al., 2010; Sirinupong et al., 2010) andnormal expres-
sion of Hand1 and Irx4 is dependent on Smyd1-skNAC interaction
(Park et al., 2010). It is not clear if the defect in cardiac develop-
ment and cardiac-speciﬁc gene expression in Symd1deletedmouse
is directly related to its HMTase activity (Tan et al., 2006; Just et al.,
2011). Interestingly Symd1 interacts with sarcomere protein and
potentially methylates myosin protein (Just et al., 2011; Li et al.,
2013). Symd1 can also function as a transcriptional repressor by
recruiting class I HDAC (Gottlieb et al., 2002; Costantini et al.,
2005).
Another Smyd family member, Smyd2, is a H3K4 and H3K36
HMT that is highly expressed in neonatal CMs. A CM-speciﬁc
KO of Smyd2 showed it is dispensable for normal cardiac devel-
opment and had no effect on H3K4 and H3K36 methylation in
mice, perhaps due to redundant HMTs that can compensate for
the Smyd2 deﬁcient (Diehl et al., 2010). Wolf-WHSC1 is a H3K36
HMT, which catalyzes mono-, di-, and tri-methylation. Dele-
tion of WHSC1 is observed in all patients with Wolf–Hirschhorn
Syndrome, which is associated with cardiac congenital defects
(Bergemann et al., 2005). WHSC1 KO mice die perinatally with
atrial and ventricular septal defects (Nimura et al., 2009). WHSC1
interacts with Nkx2.5 and occupies Nkx2.5 target genes to repress
transcription presumably through H3K36me3 modiﬁcation. Dis-
tinct H3K36me methylation patterns have been described for
end-stage cardiomyopathic compared to age-matched normal
human hearts (Movassagh et al., 2011), suggesting proper regu-
lation of H3K36me may be important for cardiac development
and maintaining physiological ACMs gene expression in humans
as well.
Histonemethyltransferases have also been implicated in cardiac
health anddisease. PRC2 is aHMTcomplex,which consists of four
components: catalytic subunit enhancer of Zeste 1 (Ezh1)/Ezh2,
suppressor of Zeste 12 (Suz12), embryonic ectoderm develop-
ment (Eed), and RbAp46/48 (Margueron and Reinberg, 2011).
PRC2 mediates the methylation of H3K27, which silences genes
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and regulates tissue-speciﬁc differentiation by orchestrating the
repression of unnecessary or stage-speciﬁc transcriptional pro-
grams (Boyer et al., 2006; Pasini et al., 2007; Shen et al., 2008).
During CM development, H3K27me3 levels increase when car-
diac progenitor cells are differentiating intoCMs (Delgado-Olguin
et al., 2012). In the heart, Ezh1 and Ezh2 are predominantly
expressed in adult and embryonic stage, respectively (Sdek et al.,
2011). The importance of PRC2 in cardiac development has been
demonstrated using cardiac-speciﬁc deletion models (Chen et al.,
2012; Delgado-Olguin et al., 2012; He et al., 2012a). Conditional
inactivation of Ezh2 speciﬁcally in right ventricle progenitors by
Mef2cAHF-Cre, which is active from E7.5, caused right ventri-
cle hypertrophy (Delgado-Olguin et al., 2012). This hypertrophy
was caused by derepression of Six1 gene which is stably silenced
upon cardiac differentiation. Nkx2.5-Cre driven Ezh2 inactiva-
tion in early cardiac differentiation caused embryonic lethality
with defects in heart development; however, inactivation of Ezh2
in differentiated CMs by TnT-Cre did not evoke a phenotype
(He et al., 2012a). The developmental defect in Ezh2 deﬁcient
mice was associated with aberrant expression of non-cardiac and
cell cycle inhibitor genes and ectopic expression of atrial-speciﬁc
genes in ventricular myocytes. These ﬁndings indicate that Ezh2
and H3K27me3 promote and stabilize cardiac differentiation by
silencing ectopic gene programs. Interestingly, Ezh2 directly binds
to GATA4 and also methylates it, which attenuates its transcrip-
tional activity by reducing its interaction with p300. This interact
is important for suppression of αMHC expression in embry-
onic CMs (He et al., 2012b). G9a and GLP are major H3K9
mono- and dimethyltransferases and contribute to transcriptional
silencing. Nkx2.5-Cre driven dual function loss of GLP and G9a
(GLP-KO/G9a-KD) mice showed reduction of H3K9me2 level in
CM and atrioventricular septal defects, but not in single either
GLP or G9a function loss (Inagawa et al., 2013). Array analysis
revealed expression of non-CM gene in GLP-KO/G9a-KD CM.
Suv39h1 which mediates tri-methylation of H3K9 can regulate
cell cycle exit in cardiac differentiation (Sdek et al., 2011). Silenc-
ing of Suv39h1 in ACMs by siRNA increased the expression of
cell cycle progression genes and consistent with this silencing of
HP1γ which binds H3K9me3, also induced cell cycle progression
gene upregulation (Sdek et al., 2011). Thus deposition of suppres-
sive histone marks such as H3K9me2/3 and H3K27me3 seems
to be involved in non-cardiac gene silencing and cell cycle exit
(Figure 1B).
Jumonji, coded by the Jarid2 gene, is a nuclear factor that
plays an essential role in the development of multiple tissues,
including the heart. Jmj has a DNA binding domain, ARID, and
two conserved Jmj domains (JmjN and JmjC; Takeuchi et al.,
2006). Based on homology to the Jmj domain, it is now rec-
ognized that this protein is part a family of proteins, most of
which are associated with histone modifying activity. The JmjC
domain is essential for the demethylase activity (Klose et al., 2006;
Takeuchi et al., 2006). The identiﬁcation that the Jmj family pro-
teins have HDM activity, which can demethylate mono-, di and
tri-methylation, suggested that histonemethylationmight bemore
dynamic than previously thought and regulate acute changes
in gene expression (Bose et al., 2004; Tsukada et al., 2006; Lan
et al., 2008; Lee et al., 2012). The Jmj family member Jmjd6 is
a histone H3 and H4 arginine demethylase that is essential for
cardiac development (Chang et al., 2007). Jmjd6-deﬁcient mice
die perinatally due to cardiac malformations with ventricular
septal defect and double-outlet right centicle (Schneider et al.,
2004). Kdm4a is a H3K9me3 and H3K36me3 HDM (Whet-
stine et al., 2006). In failing hearts ANP and BNP promoters
have less enrichment of H3K9me3 (Hohl et al., 2013). Consistent
with this Kdm4a is upregulated and enriched on these promoters
(Zhang et al., 2011; Hohl et al., 2013). Although cardiac-speciﬁc
Kdm4a deﬁcient mice and transgenic mice which overexpress
Kdm4a show no overt baseline phenotype (Zhang et al., 2011),
when subjected to pressure overload, inactivation of Kdm4a
attenuates hypertrophic response while Kdm4a overexpression
enhances cardiac hypertrophy (Zhang et al., 2011). This Kdm4a
mediated hypertrophy can be related to the expression of FHL1,
a key component of the mechanotransducer machinery which
is involved in hypertrophic development (Sheikh et al., 2008),
via demethylation of H3K9me3 on FHL1 promoter. Recently
another JmjC protein ubiquitously transcribed tetratricopeptide
repeat, X chromosome (UTX), a H3K27 demethylase encoded
on X chromosome, was shown to be essential for cardiogenesis
(Agger et al., 2007; Hong et al., 2007; Lan et al., 2007). UTX is
highly expressed in developing hearts and its deletion in female
mice is embryonic lethal with severe cardiac malformation (Lee
et al., 2012). UTX null embryonic stem cells (ESCs) also fail
to develop spontaneous contractions and cardiac-speciﬁc gene
expression (ANP, MLC2, and a-CA). UTX interacts with core
cardiac TFs, Nkx2.5, Tbx5, GATA4, and serum response factor
(SRF) as well as cardiac-speciﬁc enhancer of Brg1-associated fac-
tor Baf60c and potentiates their transcriptional activity to activate
cardiac-speciﬁc genes (Lee et al., 2012). Interestingly, in addi-
tion to H3K27me3, UTX can also affect H3K4 methylation for
activation of cardiac enhancers (Lee et al., 2012). This is likely
to be an indirect effect of the loss of UTX due to the fact that
UTX and MLL3/4 are in the same complex. Thus removal of
silencing histone marks is important for cardiac-speciﬁc gene
activation.
EPIGENETIC REGULATION OF CM TERMINAL
DIFFERENTIATION
Terminal differentiation is not the only situation under which
adult cells become postmitotic. Senescent cells also undergo an
irreversible cell cycle arrest. In both situations, cells are unable to
express the genes required for proliferation, even when stimulated
with growth factors. At themolecular level, nuclei of senescent and
terminally differentiated cells demonstrate accumulation of het-
erochromatin. This heterochromatin is a characteristic feature of
the irreversible cell cycle exit of senescent and terminally differen-
tiated cells (Narita et al., 2003; Brero et al., 2005; Sdek et al., 2011,
2013). Large-scale chromatin condensation and the reorganiza-
tion of nuclear domains reduce the accessibility of transcription
machinery within heterochromatic loci (Grewal and Jia, 2007).
Localization of E2F target genes in heterochromatin regions is
seen in both senescent and terminally differentiated cells (Narita
et al., 2003; Sdek et al., 2011). Heterochromatic regions are charac-
terized by histone hypoacetylation and enrichment of H3K9me3.
Chromatin of proliferating embryonic CMs is hyperacetylated
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(H3K9/14, H3K18, and H3K27), but following adult differenti-
ation, acetylation deceases and histone methylation (H3K9me3
and H3K27me3) associated with transcriptional repression pre-
dominates (Sdek et al., 2011).
HISTONE ACETYLATION
Histone deacetylation mediated by HDACs is the initial step of
heterochromatin assembly. Although little is known about the
function of HDACs in CMs terminal differentiation, among the
over 18 HDAC family members, HDAC1 plays critical role in reg-
ulation of proliferation in other cell types; however, the effects
of HDAC1 on cell cycle are developmentally dependent. Deletion
of HDAC1 results in embryonic lethality at E9.5 due to impaired
cellular proliferation (Lagger et al., 2002). However, in cellular
senescence, HDAC1 promotes irreversible silencing of prolifera-
tion related genes (Stadler et al., 2005; Bandyopadhyay et al., 2007;
Willis-Martinez et al., 2010; Chuang and Hung, 2011). HDAC1
and hypo-phosphorylated Rb protein levels are elevated in senes-
cent cells (Narita et al., 2003; Wang et al., 2008). HDAC1 forms
a complex with Rb and E2F4 on the E2F-dependent promoters
and is responsible for deacetylating histone H3 on E2F-dependent
promoters (Wang et al., 2008). A critical role for HDAC1 in termi-
nal differentiation has been revealed in several cell types (Stadler
et al., 2005; Yamaguchi et al., 2005; Ye et al., 2009). HDAC1 is
required for the switch from proliferation to differentiation by
antagonizing Wnt and Notch signaling pathways to promote cell-
cycle exit and the subsequent neurogenesis in zebraﬁsh retina
(Yamaguchi et al., 2005). Loss of HDAC1 in retina results in
failure of differentiation, which correlated well with failure of
precursor cells exit cell cycle and upregulation of proliferation
promoting proteins (Stadler et al., 2005). An inducible-cardiac-
speciﬁcmodel to deleteHDACs at different stages indifferentiating
CMs might shed light on the speciﬁc roles of HDACs in CMs
differentiation.
H3K9 METHYLATION
Di- and tri-H3K9me at promoters of growth-promoting genes is
critical feature of cellular senescence and terminal differentiation
associated with gene repression (Narita et al., 2003; Kotake et al.,
2007; Sdek et al., 2011). However, it is not clear if H3K9me2 and
H3K9me3 are equally important in gene silencing of postmitotic
cells. Establishment of H3K9me2 andH3K9me3 requires different
methyltransferases (G9a/GLP and Suv39h1/2 respectively), and
the nuclear sublocalization of these two modiﬁcations in postmi-
totic cells is different. H3K9me2 is found in both euchromatin
and heterochromatin regions while H3K9me3 is exclusively co-
localized with heterochromatin (Sdek et al., 2011). This ﬁnding
suggests H3K9me2 and H3K9me3 have slightly different roles in
the repression of gene expression. Since Rb is intimately involved
in targeting these methylations, knocking out Rb family mem-
ber expression in speciﬁc cell types allows dissection of the roles
of H3K9me2 and H3K9me3 in terminally differentiated cells
(Sdek et al., 2011). Acute depletion of Rb alone does not trig-
ger cell cycle reentry in ACMs although it dramatically reduces
H3K9me2 levels, indicating H3K9me2 is dispensable for main-
tenance of the postmitotic state in ACMs (Sdek et al., 2011). In
contrast, deleting both Rb and p130 disrupts heterochromatin
and allows cell cycle reentry in ACMs; however, H3K9me3 levels
were unchanged (Sdek et al., 2011), which suggests H3K9me3 is
established and maintained by an Rb-independent pathway and
the presence of H3K9me3 alone is not sufﬁcient for heterochro-
matin formation in CMs. In contrast in vitro experiments have
shown that knockdown of Suv39h1 resulted in de-suppression of
cell cycle gene and terminal differentiation failure in myocytes,
suggesting that H3K9me3 is, at least, necessary for establishing
myocyte terminal differentiation (Ait-Si-Ali et al., 2004; Sdek et al.,
2011).
H3K9me2/3 MEDIATOR HP1
The ability of Rb to stably repress transcription is related to its
capacity to recruit HP1s to target gene promoters resulting in their
incorporation into heterochromatin (Nielsen et al., 2001; Narita
et al., 2003). HP1 is a family of proteins (HP1α, -β, and -γ)
that play an important role in gene silencing in many organ-
isms (James and Elgin, 1986; Kellum, 2003) by establishing and
maintaining heterochromatin (Daniel et al., 2005). HP1 family
members typically differ in their subcellular localization and inter-
action partners and thus likely have distinct cellular functions
(Minc et al., 1999, 2001; Auth et al., 2006). A p130 and HP1α
complex is recruited to E2F regulated promoters during neu-
ronal differentiation to induce cell cycle exit (Panteleeva et al.,
2007). Rb directly promotes permanent cell cycle exit in senes-
cent cells by recruiting HP1γ to E2F responsive promoters that
have undergone methylation of H3K9 (Narita et al., 2003). The
role of HP1s in the heart largely remains unknown. All three
HP1 family members are expressed in ACMs although their sub-
nuclear localization differs. HP1γ in particular is essential for
stably repressing proliferation-promoting genes in ACMs, and
although HP1 family members share similar structure, HP1α and
HP1β could not compensate for the loss of function of HP1γ in
CMs (Sdek et al., 2011). HP1γ binds to G2/M and cytokinesis
gene promoters in ACMs but disassociated from these promot-
ers when Rb/p130 were acutely deleted, although H3K9me3 levels
at G2/M and cytokinesis gene promoters remained intact. The
dissociation of HP1γ at G2/M and cytokinesis gene promoters
correlated with loss of heterochromatin in ACMs’ nuclei, re-
expression of G2/M and cytokinesis genes as well as cell cycle
re-entry. Given the important role of HP1s in heterochromatin
formation, the absence of HP1γ recruitment appeared to be the
key factor in the disruption of heterochromatin and the reinduc-
tion of proliferation capacity in ACMs lacking Rb/p130. Thus,
in CM terminal differentiation, Rb and p130 serve as a bridge
to link histone modiﬁcations and heterochromatin formation
through their interaction with HP1γ. Heterochromatin stably
represses the expression of proliferation-promoting genes and
maintains the postmitotic phenotype of ACMs (Sdek et al., 2011;
Figure 1C).
H3K27 METHYLATION
The role of H3K27me3 in terminal differentiation is not clear
although the promoters of proliferation related genes displayed
higher levels of H3K27me3 in ACMs and skeletal myotubes (Blais
et al., 2007; Sdek et al., 2011). H3K27me3 is important for sta-
ble gene repression, including suppression of E2F-dependent
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genes, in certain contexts (Blais et al., 2007). ACMs from mice
where Rb and p130 were deleted embryonically did not undergo
permanent cell cycle exit (MacLellan et al., 2005). H3K27me3
and heterochromatin formation in these CMs were dramatically
impaired although global H3K9me3 levels were unchanged (Sdek
et al., 2011). H3K27me3 is not exclusively enriched on hete-
rochromatin, indicating H3K27me3 might relate to early stages
of heterochromatin formation and repression of genes required
for proliferation.
Rb REGULATION OF EPIGENETIC GENE SILENCING
Rb is the prototypical member of a gene family encoding three
structurally and functionally similar proteins, Rb, p107, and p130
(Chen et al., 1996). Rb also plays critical roles in senescence
and terminal differentiation associated with irreversible growth
arrest including CMs (Narita et al., 2003; Sdek et al., 2011). Rb
mediated inhibition of gene expression can be achieved by two
mechanisms: direct inhibition of E2F or recruitment of epi-
genetic remodeling factors (Gonzalo and Blasco, 2005). These
two mechanisms are selective: some promoters are repressed by
the ﬁrst mechanism, whereas other promoters, particularly cell
cycle genes, are silenced by the second mechanism (Brehm et al.,
1998; Luo et al., 1998; Angus et al., 2004). Rb family members
associate with multiple chromatin remodeling factors, including
HDACs (Luo et al., 1998; Magnaghi-Jaulin et al., 1998), Suv39h1
(Nielsen et al., 2001),HP1 (Nielsen et al., 2001), Ezh2 (Tonini et al.,
2004), Pc2 (Dahiya et al., 2001), and DMNT1 (Robertson et al.,
2000). Thus Rb affects a wide range of epigenetic regulation path-
ways, including histone acetylation, histonemethylation andDNA
methylation.
The major effect of Rb on the histone acetylation path-
way is facilitating deacetylation of target gene promoters by
recruiting HDACs (Brehm et al., 1998; Luo et al., 1998; Magnaghi-
Jaulin et al., 1998). Class I HDACs (HDAC1, −2, and −3)
directly interact with Rb through the pocket domain (Lai et al.,
1999). Similar to many Rb-interacting proteins, HDAC1 con-
tain an leucine-X-cysteine-X-glutamic acid, X stans for any any
amino acid (LXCXE) motif, which allows direct interaction with
Rb (Magnaghi-Jaulin et al., 1998). Recruitment of HDAC1 to
E2F-regulated promoters is important for Rb-mediated S phase
repression (Brehmet al., 1998). Rb also regulatesH3K9me3,which
is important for gene silencing and heterochromatin formation.
Histone methltransferase, Suv39h1/2, is speciﬁcally required for
H3K9me3 establishment and maintenance (Schotta et al., 2004;
Siddiqui et al., 2007). Rb physically interacts with Suv39h1 and it
has been suggested that this interaction is critical for Suv39h1’s
gene suppression activity (Nielsen et al., 2001). Recent studies,
however, have demonstrated that global levels of H3K9me3 is nor-
mal in ﬁbroblasts that are triply deﬁcient for Rb, p107 and p130
(Gonzalo et al., 2005; Siddiqui et al., 2007), indicating that Rb
family members are dispensable for Suv39h1 imposed H3K9me3.
H3K9me3 is speciﬁcally recognized by HP1 protein, and the bind-
ing of HP1 protein at H3K9me3 site is important to transmit
its biological signals (Bannister et al., 2001; Lachner et al., 2001;
Nakayama et al., 2001). HP1 also recruits Suv39h1 and propa-
gates H3K9me3 to adjacent chromatin (Yamamoto and Sonoda,
2003; Hathaway et al., 2012). Thus, heterochromatin formation is
a self-assembling framework of “tethers” (H3K9me3) and “adap-
tors” (HP1) where the HP1 molecules bound to neighboring
nucleosomes dimerize through their chromoshadow domains,
leading to HP1-nucleosome complexes and chromatin conden-
sation (Breitbart et al., 1985; Hathaway et al., 2012). HP1s contain
an LXCXE (or LXCXD) motif which allows interaction with both
Rb and p130 (Nielsen et al., 2001; Panteleeva et al., 2007); thus
RB can directly target HP1 on cell cycle gene promoters (Nielsen
et al., 2001; Panteleeva et al., 2007; Sdek et al., 2011), which seems
to be a key step for the initiation of terminally differentiation
and senescence. These ﬁndings are supported by fact that the
absence of Rb results in loss of heterochromatin and disrupted
H3K9me3 nuclear distribution, even though global H3K9me3 is
intact (Narita et al., 2003; Gonzalo et al., 2005; Sdek et al., 2011;
Zhang et al., 2013).
It has been demonstrated that Rb is also required for establish-
ment and maintenance of H3K27me3 (Blais et al., 2007; Kotake
et al., 2007). Rb physically interacts with PRC2, the major enzyme
complex that methylates H3K27. In growing human and mouse
primary cells, expression of p16, a prominent cell cycle inhibitor,
is repressed by H3K27me3 at the p16 locus, which is established
by PRC2. This recruitment of PRC2 is Rb dependent (Kotake
et al., 2007). In contrast Rb also interacts with Pc2, the effec-
tor protein of the PCR1 complex that recognizes and binds to
H3K27me3 (Dahiya et al., 2001; Cao et al., 2002); it has been
reported that Pc2 cooperates with Rb to inhibit expression of
cyclin A and cdc2 in senescence cells (Dahiya et al., 2001). The
mechanism underlying this function switching of Rb remains to
be elucidated.
Importance of Rb on CM terminal differentiation through
epigenetic mechanism was demonstrated (Sdek et al., 2011).
Although cardiac-speciﬁc information is limited, epigenetic role
of Rb has been demonstrated in senescence and cell line model.
Potentially the similar mechanisms discussed above are mediating
CM terminal differentiation.
CONCLUSION
Commitment to a particular lineage requires both the repres-
sion of unnecessary genes while simultaneously up-regulating
lineage-speciﬁc genes. High-throughput DNA sequencing tech-
nology has enable the search for the binding sites of cardiac TFs,
enhancers, epigenetic marked histones and chromatin modify-
ing factors on a genome-wide level by ChIP-sequencing (Blow
et al., 2010; He et al., 2011; Paige et al., 2012; Wamstad et al.,
2012; Papait et al., 2013). Core cardiac TFs such as Nkx2.5, Mef2c,
GATA4, Tbx5, and SRF and cell cycle master regulator RB/p130
have been shown to form complexes with epigenetic modifying
proteins and these complex multimers lead to modiﬁcations of
histones at promoters of cardiac and cell cycle genes which locks
in the ACM phenotype. This review has attempted to summa-
rize the advances that have been made in our understanding of
epigenetic regulation in cardiac differentiation and development.
Although increasing evidence suggests crucial roles of epigenetic
modifying proteins and epigenetic marks, their speciﬁc function
in cardiac lineage commitment and differentiation as well as their
orchestrating mechanisms still remain to be elucidated. Regard-
less, understanding this epigenetic regulation will undoubtable
Frontiers in Genetics | Epigenomics and Epigenetics November 2014 | Volume 5 | Article 375 | 6
Oyama et al. Epigenetic regulation of cardiac proliferation
uncover new insights into cardiovascular biology and poten-
tially facilitate development of novel targets for cardiovascular
therapeutics and regeneration.
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